Statement by Ralph G. Neas, President and CEO, GPhA on Generic Drug Access in Medicare Part D
December 18, 2014
December 18, 2014
WASHINGTON, Dec. 18 -- Generic Pharmaceutical Association issued the following statement by Ralph G. Neas, President and CEO:
"GPhA applauds the new findings of the Senate Special Committee on Aging and welcomes further conversation on increasing generic drug utilization in government programs, particularly Medicare Part D. Indeed, as the report, Medicare Part D Prescription Drug Benefit: Increasing Use and Access of Affordable Prescription Drugs, states, competition from gen . . .
"GPhA applauds the new findings of the Senate Special Committee on Aging and welcomes further conversation on increasing generic drug utilization in government programs, particularly Medicare Part D. Indeed, as the report, Medicare Part D Prescription Drug Benefit: Increasing Use and Access of Affordable Prescription Drugs, states, competition from gen . . .